Table 4.
Effects of CPhGs on the Hyp content and TGF-β 1 of hepatic fibrosis rats
| Group | Dose (mg/kg/day) | n | Hyp (μg/mg) | TGF-β 1 (ng/ml) |
|---|---|---|---|---|
| Normal | — | 12 | 125.61 ± 57.118* | 16.58 ± 2.814** |
| Model | — | 11 | 196.70 ± 82.545 | 31.24 ± 6.726 |
| BJRG | 600 | 10 | 129.57 ± 36.806 | 20.16 ± 4.638** |
| CPhGs | 500 | 12 | 132.77 ± 50.705 | 21.75 ± 3.711** |
| 250 | 9 | 134.99 ± 64.824 | 22.93 ± 3.576** | |
| 125 | 10 | 139.14 ± 41.352 | 23.03 ± 4.212** |
Values are expressed as mean ± SD, n = Survival number of animals
* P < 0.05, Compared with the model group; ** P < 0.01, Compared with the model group